BSECompany Update2d ago · 27 Jul 2026, 02:26 pm

Please find attached herewith intimation for Analyst / Investor Meet.

Alkem Laboratories Ltd · 539523

✦ AI SummaryResults

Alkem Laboratories Ltd. invites investors and analysts for a conference call on August 14, 2026, to discuss its Q1FY27 financial results.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

97af6d3c-4d91-4120-a4b5-f8075080686c.pdf

pdf

Download →
View document text
27th July, 2026 The Corporate Relationship Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai 400 001. Mumbai 400 051. Scrip Code: 539523 Scrip Symbol: ALKEM Sub: Intimation of Conference Call on Q1FY27 Dear Sir(s) / Madam, With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q1FY27 financial results will be held on Friday, 14th August, 2026 at 04.30 p.m. Please find attached herewith the conference call details. Kindly take note of the same. Sincerely, For Alkem Laboratories Limited Divya Mewani Vice President – Legal & Deputy Company Secretary Invite for Q1FY27 Conference Call at 4.30 pm IST, August 14, 2026 Mumbai, July 27, 2026: Alkem Laboratories Ltd. (NSE: ALKEM, BSE: 539523, Bloomberg: ALKEM.IN, Reuters: ALKE.NS) will hold a conference call for investors and analysts on Friday, August 14, 2026, from 4:30 pm to 5:30 pm IST to discuss its Q1FY27 financial results. The call will follow the announcement of the Company’s Q1FY27 financial results on Friday, August 14, 2026. Alkem Laboratories Ltd. will be represented on the call by: Mr. Sandeep Singh - MD Mr. Nitin Agrawal – CFO Motilal Oswal Securities Ltd. will host the call. Details of the conference call are as follows Time 4:30 pm IST (GMT + 5:30) on Friday, August 14, 2026. Dial in Details India +91 22 6280 1149 / +91 22 7115 8050 International Toll-Free USA 1 866 746 2133 UK 0 808 101 1573 Singapore 800 101 2045 Hong Kong 800 964 448 Express Join with Diamond Pass https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=6179 880&linkSecurityString=34f8c9ec58 You are requested to dial in 10 minutes ahead of the scheduled start time. Purvi Shah / Isha Trivedi Tushar Manudhane Investor Relations / Media Institutional Research Analyst - Healthcare Alkem Laboratories Ltd. Motilal Oswal Securities Ltd. Mobile: +91 84337 00890 / 98925 90003 Tel.: +91 22 6129 1536 / +91 82911 38039 Tel.: +91 22 3982 9999 Ext: 9447 E-mail: Tushar.Manudhane@motilaloswal.com E-mail: purvi.shah@alkem.com/ isha.trivedi@alkem.com